# Tempest Therapeutics, Inc.: Form 8-K, filed Aug 18, 2026

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: 8-K
- Filed: 2026-08-18
- Accepted by EDGAR: Aug 18, 2026, 16:27 ET
- Period: 2026-08-17
- Accession: 0001193125-26-355550
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000119312526355550/d919907d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000119312526355550/

## Items reported

- Item 5.07: Shareholder vote results
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000119312526355550/d919907d8k.htm

Filed Aug 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-355550. Last ingested by Listed: Nov 11, 2026, 00:25 ET. No prices; not investment advice.